Allakos, Inc.

11 articles with Allakos, Inc.

• 

  Clinical Catch-up for August 5-9

  8/12/2019

  Last week was a particularly busy week for biopharma companies to release information about ongoing clinical trials. Here’s a look.
• 

  Roche Gets in on Bay Area Allakos' $100M Funding Round

  12/13/2017

  The round was led by NEA and included Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital, and a large institutional investor.

• Bay Area's Allakos Taps Former ZS Pharma CEO As New Leader

  8/15/2017

• Allakos Expands License Agreement With The Johns Hopkins University School of Medicine

  11/29/2016

• Allakos Appoints Steven P. James To Board Of Directors

  11/3/2016

• Allakos Antibodies Shown To Inhibit Fibrosis, A Common Cause Of Organ Failure

  9/26/2016

• Allakos Begins Clinical Trials Of AK002 In Patients With Systemic Mastocytosis

  9/15/2016

• Allakos Initiates Phase 2 Trial Of AK001 In Patients With Nasal Polyposis

  9/8/2016

• Allakos Successfully Completes Dosing In Phase 1 Clinical Trial Of AK001 And Announces Expansion Of Its Executive Team

  1/19/2016

• Bay Area Startup Allakos Locks In Another $10 Million

  9/30/2014

• Allakos Completes Series A Financing of $32 Million

  12/17/2012